14 results
10-Q
2023 Q1
EX-10.1
COYA
Coya Therapeutics Inc
10 May 23
Quarterly report
7:14am
Package.
“DRL Royalty Term” means on a country by country basis, the period beginning on the first commercial sale following receipt of Regulatory … , distribution, use or sale of any of the Final Products in the Territory.
“Technical Package” shall mean the documentation with respect to the Product
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
, or the CARES Act, was signed into law to address the COVID-19 crisis. The CARES Act is an approximately $2 trillion emergency economic stimulus package
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
is an approximately $2 trillion emergency economic stimulus package that includes numerous U.S. federal income tax provisions, including the modification
S-1/A
5gqif8
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
EX-10.7
ijie85sxumlil
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-10.7
hnt9zak92
18 Nov 22
IPO registration
5:06pm
S-1
l95lfsr6li44
18 Nov 22
IPO registration
5:06pm
DRS/A
dirvurvyn
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
z0mnhrio bwu5e0pfy7
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
krxd14lc75p je
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next